Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age more than 18 year ECOG 0/1 Good renal, hepatic and CBC Women with biopsy proven squamous, adeno or adenosquamous carcinoma Stage III and IVA FIGO (2018)
Exclusion criteria
Exclusion criteria: Patients with early stage cancer stage I and II metastaic disease at presentation autoimmune disease patient who not willing for study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression free survival in FIGO stage III and IVa patient after giving NACTTimepoint: progression free survival in FIGO stage IIIand IVa patient after giving NACT after 8week of completion of radiation | — |
Secondary
| Measure | Time frame |
|---|---|
| progression free survivalTimepoint: At baseline;radiation side effect compliance and tolerabiltyTimepoint: baseline | — |
Countries
India
Contacts
Datta Meghe Institute of higher education and research centre